Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Alirocumab and cardiovascular outcomes after acute coronary syndrome
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Alirocumab and cardiovascular outcomes after acute coronary syndrome'. Together they form a unique fingerprint.
Acute Coronary Syndrome
Pharmacology, Toxicology and Pharmaceutical Science
100%
Alirocumab
Pharmacology, Toxicology and Pharmaceutical Science
100%
Placebo
Pharmacology, Toxicology and Pharmaceutical Science
66%
Statin (Protein)
Pharmacology, Toxicology and Pharmaceutical Science
33%
Low Density Lipoprotein Cholesterol
Pharmacology, Toxicology and Pharmaceutical Science
33%
Ischemic Cardiovascular Events
Keyphrases
22%
Adverse Event
Pharmacology, Toxicology and Pharmaceutical Science
11%
Heart Infarction
Pharmacology, Toxicology and Pharmaceutical Science
11%
Cite this